skip to Cookie NoticeSkip to contents

Brigham and Women's Hospital is open and seeing patients. All scheduled appointments and procedures will happen as planned on Monday, July 22.

Header Skipped.

Cardiovascular Medicine Research

The Brigham and Women's Hospital is world renowned for cardiovascular research. The history of the Cardiovascular and Cardiac Surgery Divisions is laden with medical firsts: the first mitral valve surgery, the first direct current cardioversion for atrial fibrillation, the first cardiac care unit, the first use of anti-arrhythmic medication following myocardial infarction, the first heart transplant in New England.

Clinical trials at Brigham and Women's Hospital have demonstrated that thrombolytic therapy (clot-busting drugs) could significantly improve a patient's chance of survival following a heart attack, that aspirin could prevent a first heart attack, that ACE inhibitors could save lives and attenuate left ventricular enlargement following a heart attack and that cholesterol lowering medication could save lives in patients following a first heart attack.

Basic scientists at Brigham and Women's hospital have identified the genes responsible for a variety of cardiac diseases, including hypertrophic cardiomyopathy and Holt-Oram syndrome, have made significant progress towards the understanding of coronary and vascular disease, endothelial function, cardiac mechanics and heart failure.